Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Rheumatology Reports
Published in: Current Rheumatology Reports 5/2017

01-05-2017 | Rheumatoid Arthritis (L Moreland, Section Editor)

Fatigue in Rheumatoid Arthritis

Author: Patricia Katz

Published in: Current Rheumatology Reports | Issue 5/2017

Login to get access

Abstract

Purpose of Review

The purpose of this study was to review the current information on fatigue in rheumatoid arthritis (RA).

Recent Findings

Severe fatigue is common among individuals with RA and has a significant impact on quality of life (QOL). RA-related factors (e.g., inflammation, pain) are associated with greater fatigue, but other factors, such as obesity, physical inactivity, sleep disturbance, and depression, explain the majority of variation in fatigue. Medications targeting RA have little effect on fatigue. Instead, the most effective interventions seem to address non-RA-specific factors such as physical inactivity or use cognitive behavioral approaches. No recommendations have been made for tools to measure fatigue in RA, leading to potential difficulty comparing studies.

Summary

Although fatigue has great impact on patients’ QOL, effective interventions that are feasible for broad dissemination remain elusive. Additional multi-faceted research is needed to identify modifiable sources of fatigue. Such research would be enhanced by harmonization of fatigue measurement across studies.
Literature
1.
Carr A, Hewlett S, Hughes R, Mitchell H, Ryan S, Carr M, et al. Rheumatology outcomes: the patient’s perspective. J Rheumatol. 2003;30:880–3.PubMed
2.
Kirwan J, Heiberg T, Hewlett S, Hughes R, Kvien T, Ahlmen M, et al. Outcomes from the patient perspective workship at OMERACT 8. J Rheumatol. 2003;30:868–72.PubMed
3.
Kirwan JR, Minnock P, Adebajo A, Bresnihan B, Choy E, de Wit M, et al. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol. 2007;34(5):1174–7.PubMed
4.
Hewlett S, Chalder T, Choy E, Cramp F, Davis B, Dures E, et al. Fatigue in rheumatoid arthritis: time for a conceptual model. Rheumatology. 2011;50:1004–6.CrossRefPubMed
5.
Overman C, Kool M, Da Silva J, Geenen R. The prevalence of severe fatigue in rheumatic disease: an international study. Clin Rheumatol. 2016;35:409–15.CrossRefPubMed
6.
•• Nikolaus S, Bode C, Taal E, van de Laar M. Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review. Arthritis Care Res. 2013;65:1128–46. Systematic review of factors related to RA fatigue. CrossRef
7.
Belza B, Dewing K. Fatigue. In: Bartlett S, editor. Clinical care in the rheumatic diseases. 3rd ed. Atlanta: Association of Rheumatology Health Professions; 2006. p. 285–8.
8.
• Minnock P, Ringnér A, Bresnihan B, Veale D, FitzGerald O, McKee G. Perceptions of the cause, impact, and management of presistent fatigue in patients with rheumatoid arthritis following tumour necrosing actor inhibition therapy. Musculoskeletal Care. 2016 [epub ahead of print]. Provides a good overview of the patient’s perspective on fatigue.
9.
• van Tuyl L, Sadlonova M, Hewlett S, Davis B, Flurey C, Goel N, et al. The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-peceived remission. Ann Rheum Dis. 2016 [epub ahead of print 2016 Nov 30]. Multi-country data on patient perspectives on RA remission, including the role of fatigue.
10.
Felson D, Smolen J, Wells G, Zhang B, van Tuyl L, Funovits J, et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthrits Rheum. 2011;63:573–86.CrossRef
11.
Strand V, Wright G, Bergman M, Tambiah J, Taylor P. Patient expectations and perceptions of goal-setting strategies for disease management in rheumatoid arthritis. J Rheumatol. 2015;42:2046–54.CrossRefPubMed
12.
•• Ward M, Guthrie L, Dasgupta A. Direct and indirect determinants of the patient global assessment in rheumatoid arthritis: differences by level of disease activity. Arthritis Care Res. 2016 [epub ahead of print 2016 Jun 6]. Important information on the determinants of patient global assessments, which are used to determine treatment response.
13.
Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum. 2008;59(10):1371–7.CrossRefPubMed
14.
Hewlett S, Hehir M, Kirwan JR. Measuring fatigue in rheumatoid arthritis: a systematic review of scales in use. Arthritis Rheum. 2007;57(3):429–39.CrossRefPubMed
15.
Hewlett S, Dures E, Almeida C. Measures of fatigue. Arthritis Care Res. 2011;63(11 Suppl):S263–S86.CrossRef
16.
17.
Bartlett S, Orbai A, Duncan T, DeLeon E, Ruffing V, Clegg-Smith K, et al. Reliability and validity of selected PROMIS measures in people with rheumatoid arthritis. PLoS One. 2015;10:e0138543.CrossRefPubMedPubMedCentral
18.
Katz P, Pedro S, Michaud K. Performance of the PROMIS 29-item profile in rheumatoid arthritis, osteoarthritis, fibromyalgia, and systemic lupus erythematosus. Arthritis Care Res. epub ahead of print, 2016.
19.
Hegarty R, Conner T, Stebbings S, Treharne G. Feel the fatigue and be active anyway: physical activity on high-fatigue days protects adults with arthritis from decrements in same-day positive mood. Arthritis Care Res. 2015;67:1230–6.CrossRef
20.
Surowiec I, Gjesdal C, Jonsson G, Norheim K, Lundstedt T, Trygg J, et al. Metabolomics study of fatigue in patients with rheumatoid arthritis naïve to biological treatment. Rheumatol Int. 2016;36:703–11.CrossRefPubMed
21.
• van Steenbergen H, Tsonaka R, Huizinga T, Boonen A, van der Helm-van Mil A. Fatigue in rheumatoid arthritis; a persistent problem: a large longitudinal study. RMD Open. 2015;4:e000041. Longitudinal study of RA fatigue over 8 years of follow-up. CrossRef
22.
Castrejon I, Nikiphorou E, Jain R, Huang A, Block J, Pincus T. Assessment of fatigue in routine care on a Multidimensional Health Assessment Questionnaire [MDHAQ]: a cross-sectional study of associations with RAPID3 and other variables in different rheumatic diseases. Clin Exp Rheumatol. 2016;34:901–9.PubMed
23.
Lee Y, Frits M, Iannaccone C, Weinblatt M, Shadick N, Williams D, et al. Subgrouping of patients with rheumatoid arthritis based on pain, fatigue, inflammation, and psychosocial factors. Arthritis Rheum. 2014;66:2006–14.
24.
• Olsen C, Lie E, Kvien T, Zangi H. Predictors of fatigue in rheumatoid arthritis patients in remission or in low disease activity state. Arthritis Care Res. 2016;68:1043–8. Longitudinal study of fatigue after reaching low disease activity or remission. CrossRef
25.
Camacho E, Verstappen S, Chipping J, Symmons D. Learned helplessness predicts functional disability, pain, and fatigue in patients with recent-onset inflammatory polyarthritis. Rheumatology. 2013;52:1233–8.CrossRefPubMedPubMedCentral
26.
Druce K, Jones G, Macfarlane G, Verstappen S, Basu N. The longitudinal course of fatigue in rheumatoid arthritis: results from the Norfolk Arthritis Register. J Rheumatol. 2015;42:2059–65.CrossRefPubMed
27.
Putrik P, Ramiro S, Hifinger M, Keszei A, Hmamouchi I, Dougados M, et al. In wealthier countries, patients perceive worse impact of the disease, although they have lower objectively assessed disease activity: results from the cross-sectional COMORA study. Ann Rheum Dis. 2016;75:715–20.CrossRefPubMed
28.
Nicklin J, Cramp F, Kirwan J, Greenwood R, Urban M, Hewlett S. Measuring fatigue in RA: a cross-sectional study to evaluate the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire, Visual Analog Scales, and Numerical Rating Scales. Arthritis Care & Research. 2010;62:1559–68.CrossRef
29.
Feldthusen C, Grimby-Ekman A, Florsblad-d’Ella H, Jacobsson L, Mannerkorpi K. Explanatory factors and predictors of fatigue in persons with rheumatoid arthritis: a longitudinal study. J Rehabil Med. 2016;48:469–76.CrossRefPubMed
30.
Feldthusen C, Dean E, Forsblad-d’Elia H, Mannerkorpi K. Effects of person-centered physical therapy on fatigue-related variables in persons with rheumatoid arthritis: a randomized controlled trial. Arch Phys Med Rehabil. 2016;97:26–36.CrossRefPubMed
31.
Van Hoogmoed D, Fransen J, Bleijenberg G, van Piel P. How to assess fatigue in rheumatoid arthritis: validity and reliability of the Checklist Individual Strength. Arthritis Rheum. 2008;58(Suppl):S868.
32.
Vercoulen J, Swanink C, Fennis J, Galama J, van der Meer J, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38:383–92.CrossRefPubMed
33.
• van Dartel S, Repping-Wuts J, van Hoogmoed D, Bleijenberg G, van Riel P, Fransen J. Association between fatigue and pain in rheumatoid arthritis: does pain precede fatigue or does fatigue precede pain? Arthritis Care Res. 2013;65:862–9. Longitudinal study examining the time-ordering of pain and fatigue. CrossRef
34.
Rongen-van Dartel S, Repping-Wuts J, van Hoogmoed D, Knoop H, Bleijenberg G, van Riel P, et al. Relationship between objectively assessed physical activity and fatigue in patients with rheumatoid arthritis: inverse correlation of activity and fatigue. Arthritis Care Res. 2014;66:852–60.CrossRef
35.
Rongen-van Dartel S, Repping-Wuts H, Donders R, van Hoogmoed D, Knoop H, Bleijenberg G, et al. A multidimensional “path analysis” model of factors explaining fatigue in rheumatoid arthritis. Clin Exp Rheumatol. 2016;34:200–6.PubMed
36.
Hann DM, Denniston MM, Baker F. Measurement of fatigue in cancer patients: further validation of the Fatigue Symptom Inventory. Qual Life Res. 2000;9(7):847–54.CrossRefPubMed
37.
•• Katz P, Margaretten M, Trupin L, Schmajuk G, Yazdany J, Yelin E. Role of sleep disturbance, depression, obesity, and physical inactivity in fatigue in rheumatoid arthritis. Arthritis Care & Research. 2016;68:81–90. Included the broadest range of potential predictors of RA fatigue of any study to date. CrossRef
38.
Krupp L, LaRocca N, Muir-Nash J, Steinberg A. The Fatigue Severity Scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121–3.CrossRefPubMed
39.
Durcan L, Wilson F, Cunnane G. The effect of exercise on sleep and fatigue in rheumatoid arthritis: a randomized controlled study. J Rheumatol. 2014;41:1966–73.CrossRefPubMed
40.
Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the Functional Assessment of Chronic Illness therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol. 2005;32:811–9.PubMed
41.
Singh H, Arya S, Talapatra P, Lather K, Mathur R, Singhania A, et al. Assessment of fatigue in rheumatoid arthritis [by Functional Assessment of Chronic Illness Therapy-Fatigue score] and its relation to disease activity and anemia. J Clin Rheumatol. 2014;20:87–90.CrossRefPubMed
42.
Smolen J, Kremer J, Gaich C, DeLozier A, Schlichting D, Xie L, et al. Patient-reported outcomes from a randomised phae III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents [RA-BEACON]. Ann Rheum Dis. 2016 [epub ahead of print].
43.
Belza BL. Comparison of self-reported fatigue in rheumatoid arthritis and controls. J Rheumatol. 1995;22(4):639–43.PubMed
44.
Nicassio P, Ormseth S, Custodio M, Irwin M, Olmstead R, Weisman M. A multidimensional model of fatigue in patients with rheumatoid arthritis. J Rheumatol. 2012;39:1807–13.CrossRefPubMedPubMedCentral
45.
Inanc N, Yilmaz-Oner S, Can M, Sokka T, Direskeneli H. The role of depression, anxiety, fatigue, and fibromyalgia in the evaluation of remission status in patients with rheumatoid arthritis. J Rheumatol. 2014;41:1755–60.CrossRefPubMed
46.
Smets E, Garssen B, Cull A, De Haes J. The Multidimensional Fatigue Inventory [MFI]: psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39:315–25.CrossRefPubMed
47.
Løppenthin K, Esbensen B, Østergaard M, Jennum P, Tolver A, Aadahl M, et al. Physical activity and the association with fatigue and sleep in Danish patients with rheumatoid arthritis. Rheumatol Int. 2015;35:1655–64.CrossRefPubMed
48.
McNair D, Lorr M, Droppleman L. Profile of mood states manual. New York: Multi-health Systems, Inc; 1992.
49.
Minnock P, Veale D, Bresnihan B, FitzGerald O, McKee G. Factors that influence fatigue status in patients with severe rheumatoid arthritis [RA] and good disease outcome following 6 months of TNF inhibitor therapy: a comparative analysis. Clin Rheumatol. 2015;34:1857–65.CrossRefPubMedPubMedCentral
50.
Ware J, Kosinski M, Dewey J. How to score version 2 of the SF-36 ® Health Survey. QualityMetric Incorporated: Lincoln; 2002.
51.
•• Druce K, Jones G, Macfarlane G, Basu N. Determining pathways to improvements in fatigue in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Arthritis Rheum. 2015;67:2303–10. Empirical model of changes in RA fatigue, including both disease- and non-disease-specific factors. CrossRef
52.
• Druce K, Bhattacharya Y, Jones G, Macfarlane G, Basu N. Most patients who reach disease remission following anti-TNF therapy continue to report fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Rheumatology. 2016;55:1786–90. Longitudinal study of RA fatigue following anti-TNF therapy. CrossRefPubMed
53.
Druce K, Jones G, Macfarlane G, Basu N. Examining changes in central and peripheral pain as mediates of fatigue improvements: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Arthritis Care Res. 2016;68:922–6.CrossRef
54.
55.
Christodoulou C, Junghaenel D, DeWalt D, Rothrock N, Stone A. Cognitive interviewing in the evaluation of fatigue items: results from the patient-reported outcomes measurement information system [PROMIS]. Qual LifeRes. 2008;17:1239–46.CrossRef
56.
Cella D, Lai J, Stone A. Self-reported fatigue: one dimension or more? Lessons from the Functional Assessment of Chronic Illness Therapy—Fatigue [FACIT-F] questionnaire. Support Care Cancer. 2011;19:1441–50.CrossRefPubMed
57.
Lai J, Cook K, Stone A, Beaumont J, Cella D. Classical test theory and item response theory/Rasch model to assess differences between patient-reported fatigue using 7-day and 4-week recall periods. J Clin Epidemiol. 2009;62:991–7.CrossRefPubMedPubMedCentral
58.
•• Louati K, Berenbaum F. Fatigue in chronic inflammation—a link to pain pathways. Arthritis Res Ther. 2015;17:254. Review of potential pathways that may lead to fatigue in rheumatic diseases. Strong focus on biological factors. CrossRefPubMedPubMedCentral
59.
• Matcham F, Ali S, Hotopf M, Chalder T. Psychological correlates of fatigue in rheumatoid arthritis: a systematic review. Clin Psychol Rev. 2015;39:16–29. Systematic review of psychological and cognitive factors associated with fatigue in RA. CrossRefPubMed
60.
•• Karshidoff B, Sundelin T, Lasselin J. Role of inflammation in human fatigue: relevance of multidimensional assessments and potential neuronal mechanisms. Front Immunol. 2017:8–21. Describes multiple factors that may affect fatigue in inflammatory conditions, including systemic inflammation and specific neuronal processes.
61.
Madsen S, Danneskiold-Samsøe B, Stockmarr A, Bartels E. Correlations between fatigue and disease duration, disease activity, and pain in patients with rheumatoid arthritis: a systemaic review. Scand J Rheumatol. 2016;45:255–61.CrossRefPubMed
62.
Evers A, Verhoeven E, van Middendorp H, Sweep F, Kraaimaat F, Donders A, et al. Does stress affect the joints? Daily stressors, stress vulnerability, immune and HPA axis activity, and short-term disease and symptom fluctuations in rheumatoid arthritis. Ann Rheum Dis. 2014;73:1683–8.CrossRefPubMed
63.
Irwin M, Olmstead R, Carroll J. Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry. 2016;80:40–52.CrossRefPubMed
64.
Chauffier K, Salliot C, Berenbaum F. J S. Effect of biotherapies on fatigue in rheumatoid arthritis: a systematic review of the literature and meta-analysis. Rheumatology. 2012;51:60–8.CrossRefPubMed
65.
Walsh D, McWilliams D. Mechanisms, impact and management of pain in rheumatoid arthritis. Nature Rev Rheumatol. 2014;10:581–92.CrossRef
66.
Grøn K, Ornbjerg L, Heftland M, Aslam F, Khan N, Jacobs J, et al. The association fo fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participating in the Quest-RA program. Clin Exp Rheumatol. 2014;32:869–77.PubMed
67.
Hewlett S, Cockshott Z, Byron M, Kitchen K, Tipler S, Pope D, et al. Patients’ perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis Rheum. 2005;53(5):697–702.CrossRefPubMed
68.
Sturgeon J, Finan P, Zautra A. Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways. Nature Rev Rheumatol. 2016;12:532–42.CrossRef
69.
Haapakoski R, Mathieu J, Ebmeier K, Alenius H, Kivimäki M. Cumulative meta-analysis of interleukines 6 and 1b, tumor crosis factor a and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015;49:206–15.CrossRefPubMedPubMedCentral
70.
Miller A, Raison C. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22–34.CrossRefPubMed
71.
Capuron L, Lasselin J, Castanon N. Role of adiposity-driven inflammation in depressive morbidity. Neuropsychophamacol Rev. 2017;42:115–28.CrossRef
72.
Abad VC, Sarinas PS, Guilleminault C. Sleep and rheumatologic disorders. Sleep Med Rev. 2008;12(3):211–28.CrossRefPubMed
73.
Bjurström M, Olmstead R, Irwin M. Reciprocal relationship between sleep macrostructure and evening and morning cellular inflammation in rheumatoid arthritis. Psychosom Med. 2017;79:24–33.CrossRefPubMed
74.
Irwin M, Olmstead R, Carrillo C, Sadeghi N, Fitzgerald J, Ranganath V, et al. Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis. Sleep. 2012;35:537–43.CrossRefPubMedPubMedCentral
75.
Westhovens R, Van der Elst K, Matthys A, Tran M, Gilloteau I. Sleep problems in patients with rheumatoid arthritis. J Rheumatol. 2014;40:31–40.CrossRef
76.
Løppenthin K, Esbensen B, Jennum P, Østergaard M, Tolver A, Thomsen T, et al. Sleep quality and correlates of poor sleep in patients with rheumatoid arthritis. Clin Rheumatol. 2015;2029–39.
77.
Lee Y, Lu B, Edwards R, Wasan A, Nassikas N, Clauw D, et al. The role of sleep problems in central pain processing in rheumatoid arthritis. Arthritis Rheum. 2013;65:59–68.CrossRefPubMedPubMedCentral
78.
Katz P, Yazdany J, Trupin L, Schmajuk G, Margaretten M, Criswell L, et al. Sex differences in assessment of obesity in rheumatoid arthritis. Arthritis Care & Research. 2013;65:62–70.CrossRef
79.
80.
Mancuso C, Rincon M, Sayles W, Paget S. Comparison of energy expenditure from lifestyle physical activities between patients with rheumatoid arthritis and healthy controls. Arthritis Rheum (Arthritis Care Res). 2007;57:672–8.CrossRef
81.
Metsios G, Koutedakis Y, Veldhjuijzen van Zanten J, Stavropoulos-Kalinoglou A, Vitalis P, Duda J, et al. Cardiorespiratory fitness levels and their association with cardiovascular profile in patients with rheumatoid arthritis: a cross-sectional study. Rheumatology. 2015;54:2215–25.PubMed
82.
Hood V, Granat M, Maxwell D, Hasler J. A new method of using heart rate to represent energy expenditure: the total heart beat index. Arch Phys Med Rehabil. 2002;83:1266–73.CrossRefPubMed
83.
Brondel L, Mourey F, Mischis-Troussard C, d’Athis P, Pfitzenmeyer P. Energy cost and cardiorespiratory adaptation in the “get-up-and-go” test in frail elderly women with postural abnormalities and in controls. J Gerontol A Biol Sci Med Sci. 2005;60A:98–103.CrossRef
84.
Edwards M, Loprinzi P. Systemic inflammation as a function of the individual and combined associations of sedentary behaviour, physical activity and cardiorespiratory fitness. Clin Physiol Funct Imaging. 2016 [epub ahead of print].
85.
Kramer H, Fontaine K, Bathon J, Giles J. Muscle density in rheumatoid arthritis: associations with disease features and functional outcomes. Arthritis Rheum. 2012;64:2438–50.CrossRefPubMedPubMedCentral
86.
Baker J, Long J, Ibrahim S, Leonard M, Katz P. Men are at greater risk of lean mass deficits in rheumatoid arthritis. Arthritis Care Res. 2015;67:112–9.CrossRef
87.
Engvall IL, Elkan AC, Tengstrand B, Cederholm T, Brismar K, Hafstrom I. Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor. Scand J Rheumatol. 2008;37(5):321–8.CrossRefPubMed
88.
Giles J, Bartlett S, Andersen R, Thompson R, Fontaine K, Bathon J. Association of body fat with C-reactive protein in rheumatoid arthrits. Arthritis Rheum. 2008;58:2632–41.CrossRefPubMedPubMedCentral
89.
Powers S, Lynch G, Murphy K, Reid M, Zijdewind I. Disease-induced skeletal muscle atrophy and fatigue. Med Sci Sports Exerc. 2016;48:2307–19.CrossRefPubMed
90.
•• Morris G, Berk M, Galecki P, Walder K, Maes M. The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases. Mol Neurobiol. 2016;53:1195–219. Review of pathways that may underlie fatigue in autoimmune and inflammatory conditions, with a focus on biological factors. CrossRefPubMed
91.
•• Almeida C, Choy E, Hewlett S, Kirwan J, Cramp F, Chalder T, et al. Biologic interventions for fatigue in rheumatoid arthritis. Cochrane Database Syst Rev. 2016 [6]. Systematic review of the impact of biologic therapy on RA fatigue.
92.
•• Cramp F, Hewlett S, Almeida C, Kirwan K, Choy E, Chalder T, et al. Non-pharmacological interventions for RA fatigue. Cochrane Database Syst Rev. 2013 [8]:CD008322. Systematic review of interventions for RA fatigue.
93.
•• Rongen-van Dartel S, Repping-Wuts H, Flendrie M, Bleijenberg G, Metsios G, van den Hout W, et al. Effect of aerobic exercise training on fatigue in rheumatoid arthritis: a meta-analysis. Arthritis Care Res. 2015;67:1054–62. Systematic review of exercise interventions on RA fatigue. CrossRef
94.
Katz P, Margaretten M, Gergorich S, Kaplan S, Rush S, Trupin L. A randomized controlled trial for a physical activity intervention for RA fatigue. American College of Rheumatology; San Francisco, CA: Arthritis Rheum; 2015. p. abstract 2083.
95.
Dures E, Kitchen K, Almeida C, Ambler N, Cliss A, Hammond A, et al. “They didn’t tell us, they made us work it out ourselves”: patient perspectivies of a cognitive-behavioral program for rheumatoid arthritis fatigue. Arthritis Care Res. 2012;64:494–501.CrossRef
96.
Repping-Wuts H, van Riel P, van Achterberg T. Rheumatologists’ knowledge, attitude and current management of fatigue in patients with rheumatoid arthritis [RA]. Clin Rheumatol. 2008.
Metadata
Title
Fatigue in Rheumatoid Arthritis
Author
Patricia Katz
Publication date
01-05-2017
Publisher
Springer US
Published in
Current Rheumatology Reports / Issue 5/2017
Print ISSN: 1523-3774
Electronic ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-017-0649-5

Other articles of this Issue 5/2017

Current Rheumatology Reports 5/2017 Go to the issue

Spondyloarthritis (M Khan, Section Editors)

Treat to Target in Axial Spondyloarthritis: What Are the Issues?

Vasculitis (L Espinoza, Section Editor)

Diffuse Alveolar Hemorrhage in Autoimmune Diseases

Orphan Diseases (B Manger, Section Editor)

Bone Involvement in Rosai-Dorfman Disease (RDD): a Case Report and Systematic Literature Review

Complementary and Alternative Medicine (S Kolasinski, Section Editor)

Platelet-Rich Plasma for the Management of Hip and Knee Osteoarthritis

Scleroderma (J Varga, Section Editor)

Protein Tyrosine Phosphatases in Systemic Sclerosis: Potential Pathogenic Players and Therapeutic Targets

Scleroderma (J Varga, Section Editor)

Lung Transplantation in Patients With Systemic Sclerosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits